Assessing clinical value of new treatment strategies : ESMO-MCBS and ASCO-VF evaluation in phase III trials at ASCO Annual Meeting 2022
Source
JCO oncology practice - ISSN 2688-1527-21:9 (2025) p. 1-11
Challenges and prospects of LAG-3 inhibition in advanced gastric and gastroesophageal junction cancer : insights from the RELATIVITY-060 trial
Source
Journal of Gastrointestinal Oncology - ISSN 2078-6891-15:6 (2024) p. 2735-2738
Development and validation of the Normalized Organoid Growth Rate (NOGR) metric in brightfield imaging-based assays
Source
Communications Biology - ISSN 2399-3642-7:1 (2024) p. 1-11
Advancements in research and treatment applications of patient-derived tumor organoids in colorectal cancer
Source
Cancers - ISSN 2072-6694-16:15 (2024) p. 1-20
State-of-the-art and upcoming trends in RAS-directed therapies in gastrointestinal malignancies
Source
Current opinion in oncology - ISSN 1040-8746-36:4 (2024) p. 313-319